Method and pharmaceutical composition for reducing serum homocysteine concentration
CA 2340227 C · Owner: Wakunaga Of America Co. Ltd. · Inventors: Amagase, Harunobu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method and composition are described for reducing the elevated plasma homocysteine level in mammals (humans) by oral administration of a therapeutically effective amount of Allium plants or extracts thereof preferably garlic, with or without one or more vitamins such as B6 B12 and , folic acid in an acceptable pharmaceutical carrier. Enhanced effectiveness is achieved with a combination of Allium plants or extracts thereof preferably , garlic, with vitamins such as B6 B12 and folic acid. The described method and composition are effective for prevention treating or ameliorating , cardiovascular diseases such as myocardial infarction stroke and multiple , arteriosclerosis by the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1999 and granted January 11, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 13, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.